Mary Pasquinelli, DNP, to receive James L. Mulshine, M.D., National Leadership Award for her establishment of lung cancer screening program

Nov 3, 2021

即時リリース

リサ・ベリー・エドワーズ
社外業務担当マネージングディレクター
がん予防財団
lisa.edwards@preventcancer.org
703-519-2107

Alexandria, Va. (Nov. 3, 2021) — Mary Pasquinelli, DNP, a specialist in pulmonary and medical oncology based in Chicago, will receive the James L. Mulshine, M.D., National Leadership Award on Thursday, November 4. This award is given annually to an individual who has had a profound impact on reducing the toll of early thoracic disease on the health of Americans and people around the world. Pasquinelli is being honored for her work establishing a lung cancer screening program to benefit medically underserved communities.

がん予防財団^® will present the ninth Mulshine Award at the 18^番目 annual 定量的イメージングワークショップ. The workshop focuses on the advancement of the use of quantitative low-dose computerized tomography (LDCT) for detection and management of early thoracic disease—lung cancer, COPD and cardiovascular disease—three of the top four leading causes of death in the U.S.

The lung cancer screening program Dr. Pasquinelli created is at a federally qualified health center on the West Side of Chicago. Additionally, she published a series of highly regarded papers on her team’s screening activities with a deep interest in overcoming health disparities through the implementation of lung cancer screening.

“The James L. Mulshine, M.D., National Leadership Award allows us to recognize someone in the medical community whose significant contributions are creating better outcomes for those with or at increased risk of developing lung cancer, COPD or cardiovascular disease,” said Carolyn Aldigé, founder and CEO of the Prevent Cancer Foundation. “Our award winners, including this year’s winner, Mary Pasquinelli, have worked hard to make our world a better place, and they should be honored accordingly.”

Past recipients of the award:

2020年 – ダニエル・C・サリバン医学博士、定量的画像バイオマーカー連合（QIBA）の設立と議長としての功績により。QIBAは、放射線学をより定量的な科学にすることで患者ケアを変革することに取り組んでいます。
2019年 – アンドリュー・C・フォン・エッシェンバッハ医学博士、国立がん研究所元所長、史上最大かつ最も高額な臨床試験である国立肺スクリーニング試験（NLST）の設計、実施、管理に対して。
2018年 – シャロン・Y・ユーバンクス、米国司法省。大手タバコ会社に対する画期的な組織犯罪裁判で司法省主任検察官を務め、予想に反して政府が勝訴した。
2017年 – 故ジョン・ウォルシュ氏、COPD財団の会長兼CEO、およびアルファワン財団の会長兼創設者。
2016年 – 肺がん連合会長兼CEO、ローリー・フェントン・アンブローズ氏。患者支援団体を指導し、メディケア・メディケイドサービスセンター（CMS）による肺がん検診の適用獲得に向けた取り組みを成功に導いた功績が評価されました。
2015年 – 肺がんのスクリーニングに低線量スパイラルCTを使用する先駆者として、マウントサイナイ医療センターのクラウディア・ヘンシュケ博士、医学博士。
2014年 – CVS Health、店舗でのタバコ製品の販売を中止するという同社の大胆な決断が認められ、CVS最高医療責任者のナンシー・ガリアーノ医学博士が受賞。
2013 (Inaugural year of the Award) – Cheryl G. Healton, DrPH, President and CEO, Legacy Foundation and Dean of the College of Public Health at New York University, in recognition of over 25 years of tireless work in public health, specifically on tobacco control.

This year’s workshop will take place November 4-5 as a virtual event, with the award ceremony happening on November 4. Registration is closed, but those interested can view a recording of the award ceremony on November 5.

For more information about the Quantitative Imaging Workshop and the award, visit the Prevent Cancer Foundation website.

###

がん予防財団について^®

がん予防財団^® is celebrating 35 years as the only U.S. nonprofit organization focused solely on saving lives across all populations through cancer prevention and early detection. Through research, education, outreach and advocacy, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated.

The Foundation is rising to meet the challenge of reducing cancer deaths by 40% by 2035. To achieve this, we are committed to investing $20 million for innovative technologies to detect cancer early and advance multi-cancer screening, $10 million to expand cancer screening and vaccination access to medically underserved communities, and $10 million to educate the public about screening and vaccination options. For more information, please visit がん予防.